Initially, the managers note that the fund had a negative relative return compared to its benchmark index in October. The holdings that contributed most positively during the month were Truecaller, Invisio and TSMC, while Cellavision, Xvivo and Biotage weighed the most. October was also an important reporting month, with the majority of portfolio companies releasing their reports.
"During the month, 65 percent of the portfolio has reported figures for the third quarter and the portfolio-weighted growth excluding acquisitions and currency amounts to 16 percent so far. This is a strong figure compared to the stock market as a whole, but at the same time a marginal slowdown compared to previous quarters," the manager writes.
One Q3 report highlighted as particularly strong was that of Bonesupport, which showed 54 percent growth with an operating margin that increased from 9 to 17 percent. In contrast, Qt Group reported a worse report and saw its share price fall sharply.
"Part of their sales is linked to the number of units sold by customers and during the quarter volumes were weaker in passenger cars and consumer electronics. As a result, currency-adjusted growth amounted to just over 12 percent, which was lower than the expectations of just over 20 percent."
In terms of portfolio activity, the Fund increased its holdings in Intuitive Surgical, Onto Innovation and Yubico during the month, while decreasing its holdings in Servicenow, Smartsheet and Xvivo.
Swedbank Robur Ny Teknik, % | October, 2024 |
Fund MM, change in percent | 0,56 |
Fund this year, change in percent | 8,90 |